FILIPPO BELLATI
Structure:
Dipartimento di SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
SSD:
MEDS-21/A

Orari di ricevimento

Venerdì ore 12-14, Dipartimento di Scienze Medico Chirurgiche e Medicina Traslazionale, Sapienza Università di Roma

Curriculum

Filippo Bellati
Curriculum Vitae

Part I – General Information
Full Name Filippo Bellati
Date of Birth 26/09/1975
Place of Birth Rome
Citizenship Italian
Permanent Address Via degli Avignonesi, 5
Mobile Phone Number 0039 3471867754
E-mail filippo.bellati@uniroma1.it
Spoken Languages Italian, English

Part II – Education
Type Year Institution
High School
1994 Cheltenham College, UK
University Graduation
2001 Campus Bio Medico University 100/100 cum laude
Specialty 2006 Gynecology and Obstetric,;“Sapienza” University of Rome 70/70
Post-graduate studies 2007 Stage of robotic surgery in Gynecology, MAYO clinic Arizona
PhD 2009 Gynecology and Obstetric,;“Sapienza” University of Rome Tesis: “Effetto Immunologico della Chirurgia Citoriduttiva nel Carcinoma dell’Ovaio”

Part III – Appointments
Academic and Clinical Appointments
Start End Institution Position
1999 ongoing Medical Consultant at Research Institut of MESOMARK GROUP srl
2006 ongoing Clinical and Scientific Consultant of “UTP cell therapy and tumor immunology” “Sapienza” University of Rome
2008 ongoing Assistant Professor SSD-MED40, “Sapienza” University of Rome
2011 ongoing Attending Physician at Policlinico Umberto I, Rome (permanent employment)
05/2014 12/2014 Attending Physician at Fondazione IRCSS, Istituto Nazionale Tumori, Milan (permanent employment)
2003-2013 Participated at 335 major surgery
05/2014-12/2014 Major surgical gynecological interventions at Istituto Nazionale Tumori Milano: 158
High specilaity office visit: 877
2002-2014 Speaker and chairman at more than 40 national and international Gynecologic and Obstetric congresses
2003-2014 41 abstract, poster e oral presentation accepeted at national and international Gynecologic and Obstetric congresses

Part IV – Teaching experience
2011-ong Teaching at Degree Course of Medicine, CCLA, Course of Gynecology and Obstetrics Sapienza Università di Roma
2009-ong Teaching at Resident School of Gynecology and Obstetrics, “Università degli studi G.D’Annunzio” Chieti
2010-ong Teaching at Degree Course of Medicine, CCLA, Course of Reproductive Medicine “Sapienza” Università di Roma
2012-ong Teaching at Degree Course of Medicine, CCLD, Course of Reproductive Medicine “Sapienza” Università di Roma
2010-ong Teaching at Nursing Degree CCLR, Course of Gynecology and Obstetrics,“Sapienza” Università di Roma, Polo Latina-Terracina
2010-ong Teaching at Degree Course in “Terapia della Neuro e Psicomotricità dell’età evolutiva”“Sapienza” Università di Roma, Polo Latina- Priverno

Part VA - Society memberberships
2011-2013 Member Board of MITO (Multicentric Italian Trial on Ovarian Cancer and Gynecologic Malignancies)(Commissione Protocolli)
2011-ongoing Member Board of MITO (Multicentric Italian Trial on Ovarian Cancer and Gynecologic Malignancies) (Commissione Ricerca Traslazionale)
2011- 2013 Member Board of SIOG (Società Italiana di Oncologia Ginecologica)(Revisore dei Conti)
2011-2013 Member Board of AGUI (Associazione Ginecologi Universitari Italiani)(Tesoriere)
2011- ongoing MITO representative at GCIG (Gynecologic Cancer InterGroup )

Part VB - Awards and Honors
2003 First Place “Kurt Semm Award for Excellence in Laparoscopy”32nd Annual Meeting of the American Association of Gynecological Laparoscopists, Las Vegas.
2004 First Place “Giovani Ricercatori sotto 35 anni”XIV Congresso Nazionale AIUG, Roma.
2004 First Palce “Carlo Romanini Award for research in endometriosis”34th Annual Meeting of the American Associationof Gynecological Laparoscopists, Chicago.
2005 3rd Place “Golden Hysteroscope Award”34th Annual Meeting of the American Association of Gynecological Laparoscopists, Chicago.
2007 First Place “Best Oral Presentation”Congresso Annuale dell’Associazione Ginecologi Universitari Italiana (AGUI), Roma.
2007 Second Place “Kott Award for Best New Minimally Invasive Technique” 37th Annual Meeting of the American Association of Gynecological Laparoscopists, Washington

Part VI - Funding Information [grants as PI-principal investigator or I-investigator
2009 “Analisi della popolazione immunosoppressiva delle cellule T regolatorie come indicatore prognostico in pazienti affette da tumore dell'ovaio” euro 72.429 financed by MIUR
2010 “Designing vaccination strategies for ovarian cancer patients”euro 85.000 financed by Sapienza University of Rome

Part VII – Research Activities
The scientific interests cover the entire spectrum of Gynecology andObstetrics.
Particular attention has been given to Translational Medicine.
The findings have presented with 97 papers on peer reviewed international journals.
Referee of more than 15 papers for prestigious international indexed journal in the last 5 years ago (eg. IJGO, EJSO, EJOSO, BMC Cancer, BJC, EJC, EJOGRB).

Part VIII – Summary of Scientific Achievements
Papers [international] 97 Pubmed 2003 2014
Papers [national] 1 Pubmed 2003 2014
Books chapter 6 Tecniche chirurgiche in ginecologia oncologica.
In: Dewrhust. Trattato di Ginecologia e Ostetricia. 2012
Carcinoma dell’endometrio- Manuale pratico di oncologia.
Fondamenti per il medico non oncologo. Editeam sas, doi: 10.978.886135/1295 2011
Carcinoma dell’ovaio- Manuale pratico di oncologia. Fondamenti per il medico non oncologo. Editeam sas, doi: 10.978.886135/1295 2011
Role Of Lymphadenectomy In Gynecologic Cancers.
Textbook Of Gynaecological Oncology 2009
Vaginal Cancer.
Principles and Practice of Chemotherapy For
Gynecologic Neoplasms: Current Therapy And Novel
Approches. 2004
Vulvar Cancer.
Principles and Practice of Chemotherapy For
Gynecologic Neoplasms: Current Therapy And Novel Approches. 2004

Total Impact factor 415.15
(IF last 10 years: april 2005- april 2015: 389.25)
Total Citations 1109
Average Citations per Product 11.5

Hirsch (H) index 19
Normalized H index* 1.46
*H index divided by the academic seniority.

Part IX– Selected Publications
List of the publications selected for the evaluation. For each publication report title, authors, reference data, journal IF (if applicable), citations, press/media release (if any). (Source: Scopus)

1) Papadia A, Bellati F*, Ditto A, Bogani G, Gasparri ML, Di Donato V, Martinelli F, Lorusso D, Benedetti Panici P, Raspagliesi F. Surgical Treatment of Recurrent endometrial Cancer: Time for a paradigm shift. Ann Surg Oncol 2015. Epub ahead of print

IF: 4.18
CITATIONS: -
*role: first author (Papadia and Bellati “have eqaully contribued”)

2) Ruscito I, Dimitrova D, Vasconcelos I, Gellhaus K, Schwachula T, Bellati F, Zeillinger R, Benedetti-Panici P, Vergote I, Mahner S, Cacsire-Tong D, Concin N, Darb-Esfahani S, Lambrechts S, Sehouli J, Olek S, Braicu EI. BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients--a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD). Eur J Cancer. 2014;50(12):2090-8.

IF: 4.12
CITATIONS: 1

3) Nodale C, Ceccarelli S, Giuliano M, Cammarota M, D'Amici S, Vescarelli E, Maffucci D, Bellati F, Panici PB, Romano F, Angeloni A, Marchese C. Gene expression profile of patients with Mayer-Rokitansky-Küster-Hauser syndrome: new insights into the potential role of developmental pathways. PLoS One. 2014; 9(3):e91010.

IF: 3.53
CITATIONS: 2

4) Bellati F, Ruscito I, Gasparri ML, Antonilli M, Pernice M, Vallone C, Morano G, Chirletti P, Berloco PB, Panici PB. Effects of unilateral ovariectomy on female fertility outcome. Arch Gynecol Obstet. 2014;290(2):349-53.

IF: 0.91
CITATIONS: 1
role: First Author

5) Paroli M, Bellati F, Videtta M, Focaccetti C, Mancone C, Donato T, Antonilli M, Perniola G, Accapezzato D, Napoletano C, Nuti M, Bartolazzi A, Panici PB, Tripodi M, Palombo F, Barnaba V. Discovery of chemotherapy-associated ovarian cancer antigens by interrogating memory T cells. Int J Cancer. 2014; 134(8):1823-34.

IF: 6.20
CITATIONS: 1

6) Bellati F, Napoletano C, Ruscito I, Visconti V, Antonilli M, Gasparri ML, Zizzari IG, Rahimi H, Palaia I, Rughetti A, Benedetti Panici P, Nuti M. Past, present and future strategies of immunotherapy in gynecological malignancies. Curr Mol Med. 2013;13(4):648-69.

IF: 4.20
CITATIONS: 2
Role: first author

7) Bellati F, Napoletano C, Gasparri ML, Ruscito I, Marchetti C, Pignata S, Tomao F, Benedetti Panici P, Nuti M. Current knowledge and open issues regarding bevacizumab in gynaecological neoplasms. Crit Rev Oncol Hematol. 2012;83(1):35-46.

IF: 5.27
CITATIONS: 4 role: first author

8) Palaia I, Musella A, Bellati F, Marchetti C, Di Donato V, Perniola G, Benedetti Panici P. Simple extrafascial trachelectomy and pelvic bilateral lymphadenectomy in early stage cervical cancer. Gynecol Oncol. 2012;126(1):78-81.

IF: 3.93
CITATIONS: 12

9) Benedetti Panici P, Perniola G, Pernice M, Antonilli M, Achilli C, Di Donato V, Bellati F. Laparoscopically guided minilaparotomy: a minimally invasive approach for the treatment of gynaecologic diseases in morbidly obese patients. Eur J Obstet Gynecol Reprod Biol. 2012;160(2):210-4.

IF: 1.97
CITATIONS: -

10) Panici PB1, Di Donato V, Plotti F, Musella A, Sansone M, Angioli R, Perniola G, Bellati F. Feasibility and safety of type C2 total extraperitoneal abdominal radical hysterectomy (TEARH) for locally advanced cervical cancer. Gynecol Oncol. 2011;120(3):423-9.

IF: 3.93
CITATIONS: 2

11) Zizzari IG, Veglia F, Taurino F, Rahimi H, Quaglino E, Belleudi F, Riccardo F, Antonilli M, Napoletno C, Bellati F, Benedetti-Panici P, Torrisi MR, Frati L, Nuti M, Rughetti A. HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy. J Mol Med. 2011;89(12):1231-40.

IF: 4.77
CITATIONS: 3

12) Panici PB, Ruscito I, Gasparri ML, Maffucci D, Marchese C, Bellati F. Vaginal reconstruction with the Abbè-McIndoe technique: from dermal grafts to autologous in vitro cultured vaginal tissue transplant. Semin Reprod Med. 2011;29(1):45-54.

IF: 3.21
CITATIONS: 7
role: last name

13) Bellati F, Napoletano C, Gasparri ML, Visconti V, Zizzari IG, Ruscito I, Caccetta J, Rughetti A, Benedetti-Panici P, Nuti M. Monoclonal antibodies in gynecological cancer: a critical point of view. Clin Dev Immunol. 2011;2011:890758.

IF: 3.06
CITATIONS: 10
role: first author

14) Bellati F, Napoletano C, Gasparri ML, Panici PB, Nuti M. Immunologic systemic effect of neoadjvant chemotherapy requires investigation before tumor-associated lymphocytes can be introduced in breast cancer treatment algorithm. J Clin Oncol. 2010;28(27):e471-2

IF: 18.04
CITATIONS: 4 role: first author

15) Bellati F, Napoletano C, Ruscito I, Pastore M, Pernice M, Antonilli M, Nuti M, Benedetti Panici P. Complete remission of ovarian cancer induced intractable malignant ascites with intraperitoneal bevacizumab. Immunological observations and a literature review. Invest New Drugs. 2010;28(6):887-94.

IF: 3.50
CITATIONS: 18
role: first name

16) Bellati F, Napoletano C, Ruscito I, Liberati M, Panici PB, Nuti M. Cellular adaptive immune system plays a crucial role in trastuzumab clinical efficacy. J Clin Oncol. 2010;28(21):e369-70.

IF: 18.04
CITATIONS: 8
role: first name

17) Bellati F, Calcagno M, Panici PB. Dose-dense paclitaxel for advanced ovarian cancer. Lancet. 2010;375(9711):280

IF: 39.21
CITATIONS: -
role: first name

18) Napoletano C and Bellati F*, Landi R, Pauselli S, Marchetti C, Visconti V, Sale P, Liberati M, Rughetti A, Frati L, Panici PB, Nuti M. Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression. J Cell Mol Med. 2010;14(12):2748-59.

IF: 4.75
CITATIONS: 15
*role first name (Napoletano and Bellati “have eqaully contribued”)

19) Bellati F, Visconti V, Napoletano C, Antonilli M, Frati L, Panici PB, Nuti M. Immunology of gynecologic neoplasms: analysis of the prognostic significance of the immune status. Curr Cancer Drug Targets. 2009;9(4):541-65.

IF: 5.13
CITATIONS: 12
role: first name

20) Napoletano C, Rughetti A, Landi R, Pinto D, Bellati F, Rahimi H, Spinelli GP, Pauselli S, Sale P, Dolo V, De Lorenzo F, Tomao F, Benedetti-Panici P, Frati L, Nuti M. Immunogenicity of allo-vesicle carrying ERBB2 tumor antigen for dendritic cell-based anti-tumor immunotherapy. Int J Immunopathol Pharmacol. 2009;22(3):647-58.

IF: 2.99
CITATIONS: 9

21) Napoletano C, Bellati F, Tarquini E, Tomao F, Taurino F, Spagnoli G, Rughetti A, Muzii L, Nuti M, Benedetti Panici P. MAGE-A and NY-ESO-1 expression in cervical cancer: prognostic factors and effects of chemotherapy. Am J Obstet Gynecol. 2008;198(1):99.

IF: 3.28
CITATIONS: 25

22) Benedetti Panici P, Bellati F, Plotti F, Di Donato V, Antonilli M, Perniola G, Manci N, Muzii L, Angioli R. Neoadjuvant chemotherapy followed by radical surgery in patients affected by vaginal carcinoma. Gynecol Oncol. 2008;111(2):307-11.

IF: 3.93
CITATIONS: 10

23) Napoletano C, Taurino F, Biffoni M, De Majo A, Coscarella G, Bellati F, Rahimi H, Pauselli S, Pellicciotta I, Burchell JM, Gaspari LA, Ercoli L, Rossi P, Rughetti. RFA strongly modulates the immune system and anti-tumor immune responses in metastatic liver patients. Int J Oncol. 2008;32(2):481-90.

IF: 2.66
CITATIONS: 20

24) Bellati F, Plotti F, Panici PB. Preoperative hematocrit levels and outcomes after noncardiac surgery. JAMA. 2007;298(13):1512

IF: 29.98
CITATIONS: 1
role: first name

25) Bellati F, Napoletano C, Tarquini E, Palaia I, Landi R, Manci N, Spagnoli G, Rughetti A, Panici PB, Nuti M. Cancer testis antigen expression in primary and recurrent vulvar cancer: association with prognostic factors. Eur J Cancer. 2007;43(17):2621-7.

IF: 5.06
CITATIONS: 19
role: first name

26) Bellati F, Pernice M, Manci N, Palaia I, Tomao F, Marchetti C, Zullo MA, Muzii L, Angioli R, Benedetti Panici P. Hemoglobin variation and blood transfusion rates in patients affected by locally advanced cervical cancer undergoing neo-adjuvant chemotherapy followed by radical surgery: the role of erythropoietic growth factors. Ann Oncol. 2007;18(4):722-9.

IF: 7.38
CITATIONS: 6
role: first name

27) Napoletano C, Pinto D, Bellati F, Taurino F, Rahimi H, Tomao F, Panici PB, Rughetti A, Frati L, Nuti M. A comparative analysis of serum and serum-free media for generation of clinical grade DCs. J Immunother. 2007;30(5):567-76.

IF: 3.46
CITATIONS: 14

28) Zullo MA, Plotti F, Calcagno M, Marullo E, Palaia I, Bellati F, Basile S, Muzii L, Angioli R, Panici PB. One-year follow-up of tension-free vaginal tape (TVT) and trans-obturator suburethral tape from inside to outside (TVT-O) for surgical treatment of female stress urinary incontinence: a prospective randomised trial. Eur Urol. 2007;51(5):1376-82.

IF: 10.48
CITATIONS: 86

29) Muzii L, Bellati F, Bianchi A, Palaia I, Manci N, Zullo MA, Angioli R, Panici PB. Laparoscopic stripping of endometriomas: a randomized trial on different surgical techniques. Part II: pathological results. Hum Reprod. 2005;20(7):1987-92.

IF: 4.67
CITATIONS: 78

30) Ludovico Muzii, Filippo Bellati, Natalina Manci, Marzio A Zullo, Roberto Angioli, Pierluigi Benedetti Panici. Ringer's lactate solution remains in the peritoneal cavity after laparoscopy longer than expected. Fertility and sterility 2005; 84(1):148-53.

IF: 3.97
CITATIONS: 8